Table 4 Cumulative ranking probability of TKR main outcome indicators by different treatment measures (surface under the cumulative ranking curves, SUCRA)
| Â | The total blood loss | Transfusion | Change of Hb |
|---|---|---|---|
Control | 2(87.67%) | 4(58.56%) | 2(79.84%) |
IV TXA | 5(54.89%) | 7(38.22%) | 3(60.80%) |
Topical TXA | 3(58.00%) | 5(43.44%) | 4(54.22%) |
IV+topical TXA | 9(24.44%) | 9(24.33%) | 7(46.14%) |
Oral TXA | 6(50.22%) | 6(38.67%) | 6(51.29%) |
Placebo+tourniquet | 1(90.44%) | 1(100.00%) | 1(80.26%) |
IV TXA+tourniquet | 7(49.44%) | 3(78.78%) | 8(37.87%) |
Topical TXA+tourniquet | 4(56.33%) | 2(86.89%) | 9(37.46%) |
IV+topical TXA+tourniquet | 8(29.22%) | 8(28.56%) | 5(52.13%) |